穴位体表电刺激对术后PCEA的强化效应

目的　观察穴位体表电刺激对术后患者硬膜外自控镇痛（PCEA）效果、镇痛药用量、血清皮质醇浓度和不良反应的影响。方法　 选择经腹全宫切除术患者40例（ASAⅠ～Ⅱ级）,随机分成二组,每组20例。A组：于术后第4,8小时 Han's各刺激30 min,术后行PCEA。B组：单纯行术后PCEA（对照组）。术后随访镇痛效果、镇静评分、布氏舒适评分（BCS）,分段记录24 h镇痛药用量及总按压次数/实进次数（D1/D2）比值,血清皮质醇含量,肛门恢复排气时间和不良反应情况。结果　两组镇痛效果满意,A组BCS评分高于B组（P＜0.05）。A组镇痛药用量为（31.7±1.9）ml,与对照组（34.2±2.1）ml相比差异有显著性（P＜0.01）。血清皮质醇浓度两组均较术前下降,但A组术后8 h的下降幅度大于对照组。A组恢复肛门排气时间快于B组,而且恶心、呕吐与对照组相比有所减少。结论　术后患者硬膜外腔自控镇痛（PCEA）复合应用穴位体表电刺激,可增强镇痛效果,减少用药量,降低不良反应,是安全有效的复合镇痛方法。     

携带TPH-2基因小分子干扰RNA表达载体的构建与鉴定

目的 构建携带色氨酸羟化酶(TPH)-2基因的小分子干扰RNA表达载体.方法 设计并合成shRNA TPH-2对应的两条互补的寡核苷酸链,pU6-CMV-GFP质粒经Age Ⅰ和EcoRⅠ双酶切与退火后的寡核苷酸连接,目的 质粒转化感受态细胞,对长出的克隆应用菌落聚合酶链反应(PCR)鉴定,再对PCR鉴定阳性的克隆进行测序和比对分析.结果 经PCR、酶切及测序证实,pU6-CMV-GFP-TPH-2 shRNA表达载体片段大小为332 bp,其中插入的片段序列和位点与预期完全一致.结论 实验成功构建pU6-CMV-GFP-TPH2 shRNA表达载体.     

子宫切除术后舒芬太尼病人自控-靶控镇痛的安全性和有效性

Objective To investigate the efficacy and safety of patient-controlled analgesia (PCA) with target controlled infusion (TCI) of sufentanil after abdominal total hysterectomy. Methods Sixty ASA I or II patients aged 20-59 yr weighing 45-75 kg undergoing elective abdominal total hysterectomy were randomly allocated into 3 groups of 20 patients each. The initial target plasma concentration (CP ) of sufentanil was set at 0.08 μg/L in group I and II and at 0.1 μg/L in group Ⅲ . The operation was performed under combined spinal-epidural anesthesia with 0.75% bupivacaine (for spinal) and 2% lidocaine (for epidural). The epidural catheter was removed after operation. TCI of sufentanil was started after operation when the patients felt no pain (VAS = 0) in group I and when VAS ≥ 2 in group Ⅱ and Ⅲ . The lockout interval was set at 6 min. If the patients pressed the button once, the target CP increased by 0.005 μg/L. If the button was pressed 3 times successively within 20 s, the target CP increased by 0.008 μg/L. If the button was not pressed for 80 min, the target CP decreased by 0 .005 μg/L automatically. VAS scores, BIS values, MAP, HR, SpO2 and RR were recorded immediately before (T0) and at 1, 2, 4, 8, 16, 24 h (T1-6) after TCI was started. The number of attempts (D1) and successfully delivered doses (D2) was recorded. The total amount of sufentanil administered and side effects were recorded during the 24 h after operation. Results The analgesia was satisfactory in all 3 groups. The VAS scores were < 3 and significantly higher in group Ⅱ and Ⅲ than in group I . The total amount of sufentanil administered during the 24 h after operation was significantly larger in group II and HI than in group I . The D1 and D2 were significantly larger during the 0-2 h after operation in group Ⅱ and Ⅲ than in group I .Tachycardia, bradycardia, respiratory depression, hypotension and over-sedation were not observed. Conclusion PCA with TCI of sufentanil is effective and safe for postoperative analgesia. It is better to start PCA-TCI before the patient feels pain after operation with the initial target CP set at 0.08 μg/L.     

膝关节前交叉韧带翻修及影响首次重建疗效的相关因素分析

目的总结影响关节镜下前交叉韧带重建疗效的相关因素。方法回顾性分析135例前交叉韧带翻修病例的相关临床资料,进行膝关节Lysholm评分综合分析。结果膝关节继发性疾患、骨隧道位置、移植物的张力、髁间窝撞击、所移植肌腱的固定和术后康复训练6大因素是影响关节镜下膝关节前交叉韧带重建疗效的关键因素。结论高度重视以上6方面因素并正确处理,能有效提高关节镜下膝关节前交叉韧带重建的成功率和治疗效果。     

子宫切除术后舒芬太尼病人自控-靶控镇痛的安全性和有效性

Objective To investigate the efficacy and safety of patient-controlled analgesia (PCA) with target controlled infusion (TCI) of sufentanil after abdominal total hysterectomy. Methods Sixty ASA I or II patients aged 20-59 yr weighing 45-75 kg undergoing elective abdominal total hysterectomy were randomly allocated into 3 groups of 20 patients each. The initial target plasma concentration (CP ) of sufentanil was set at 0.08 μg/L in group I and II and at 0.1 μg/L in group Ⅲ . The operation was performed under combined spinal-epidural anesthesia with 0.75% bupivacaine (for spinal) and 2% lidocaine (for epidural). The epidural catheter was removed after operation. TCI of sufentanil was started after operation when the patients felt no pain (VAS = 0) in group I and when VAS ≥ 2 in group Ⅱ and Ⅲ . The lockout interval was set at 6 min. If the patients pressed the button once, the target CP increased by 0.005 μg/L. If the button was pressed 3 times successively within 20 s, the target CP increased by 0.008 μg/L. If the button was not pressed for 80 min, the target CP decreased by 0 .005 μg/L automatically. VAS scores, BIS values, MAP, HR, SpO2 and RR were recorded immediately before (T0) and at 1, 2, 4, 8, 16, 24 h (T1-6) after TCI was started. The number of attempts (D1) and successfully delivered doses (D2) was recorded. The total amount of sufentanil administered and side effects were recorded during the 24 h after operation. Results The analgesia was satisfactory in all 3 groups. The VAS scores were < 3 and significantly higher in group Ⅱ and Ⅲ than in group I . The total amount of sufentanil administered during the 24 h after operation was significantly larger in group II and HI than in group I . The D1 and D2 were significantly larger during the 0-2 h after operation in group Ⅱ and Ⅲ than in group I .Tachycardia, bradycardia, respiratory depression, hypotension and over-sedation were not observed. Conclusion PCA with TCI of sufentanil is effective and safe for postoperative analgesia. It is better to start PCA-TCI before the patient feels pain after operation with the initial target CP set at 0.08 μg/L.     

异丙酚对内毒素诱导人脐静脉内皮细胞过氧亚硝基阴离子生成的影响

目的 探讨异丙酚对内毒素诱导人脐静脉内皮细胞过氧亚硝基阴离子(ONOO-)生成的影响.方法 培养至活细胞计数大于95%的人脐静脉内皮细胞,随机分为7组(n=5),对照组(C组)不给予任何处理;LOS0.1组、LPS1组和LPS10组分别加入内毒素(LPS)至终浓度为0.1、1和10 μg/ml,于37℃5%CO2培养箱中孵育6 h;P4+LPS10组和P40+LPS10组预先加入异丙酚至终浓度为4、40μg/ml,I40+LPS10组预先加入脂质溶剂Introlipid至终浓度为40 μg/ml,于37℃ 5%CO2培养箱中孵育30 min,再分别加入LPS至终浓度为10μg/ml,于培养箱中继续孵育6 h.孵育6 h时,测定细胞活力和乳酸脱氢酶(LDH)释放率;采用免疫组化法和Western blot法测定硝基酪氨酸蛋白(NT)表达.结果 与C组比较,其余各组细胞活力降低,内皮细胞NT表达上调,LPS1组、LPS10组、I40+LPS10组、P4+LPS10组和P40+LPS10组LDH释放率升高(P<0.01);与LPS0.1组比较,LPS1组细胞活力、LDH释放率和内皮细胞NT表达差异无统计学意义(P>0.05),LPS10组细胞活力降低,LDH释放率升高,内皮细胞NT表达上调(P<0.01);与LPS10组比较,I40+LPS10组细胞活力、LDH释放率和内皮细胞NT表达差异无统计学意义(P>0.05),P4+LPS10组和P40+LPS10组细胞活力升高,LDH释放率降低,内皮细胞NT表达下调(P<0.01).结论 异丙酚可通过抑制ONOO'-的生成,减轻内毒素诱导人脐静脉内皮细胞损伤.     

不同液体复苏对失血性休克-内毒素二次打击大鼠急性肺损伤的影响

目的 比较不同液体复苏对失血性休克-内毒素二次打击大鼠急性肺损伤的影响.方法 60只雄性SD大鼠,体重250～280 g,随机分为5组(n=12):假手术组(S组)、失血性休克-内毒素组(SL组)、乳酸钠林格氏液组(LR组)、7.5%氯化钠组(HS组)和羟乙基淀粉(HES)130/0.4组(HES组).分为院前期(90 min)、院内复苏期(1 h)和复苏后观察期(3.5 h).院前期:SL组、LR组、HS组和HES组颈总动脉放血建立失血性休克模型(维持MAP 35～45 mm Hg 60 min)后,气管内注射内毒素2mg/kg,同时断尾,注射内毒素后即刻分别经30 min静脉输注3倍放血量的乳酸钠林格氏液、7.5%氯化钠4ml/kg和等放血量的6%HES 130/0.4;院内复苏期:结扎尾部断端止血,在1 h内回输全部放出的血液及等放血量的0.9%氯化钠;复苏后观察期3.5 h时采集动脉血样,进行血气分析,计算肺组织湿/干重量比(W/D)和肺通透指数(PPI),测定肺泡灌洗液(BALF)蛋白浓度和肺组织AQP-1 mRNA和AQP-5mRNA表达水平,光镜下观察肺组织病理学结果,记录大鼠存活情况.结果 与SL组和LR组比较,HS组和HES组MAP、pH值、PaO2和SaO2升高,血乳酸浓度、BE、W/D、PPI和BALF蛋白浓度降低,HS组肺组织AQP-1 mRNA表达上调,HES组肺组织AQP-1 mRNA和AQP-5 mRNA表达上调,大鼠存活率升高(P＜0.05或0.01);与HS组比较,HES组W/D降低,AQP-5 mRNA表达上调,大鼠存活率升高(P＜0.05),肺组织损伤程度减轻.结论 6%HES 130/0.4和7.5%氯化钠可减轻失血性休克-内毒素二次打击大鼠急性肺损伤,6%HES 130/0.4的效果更好,其机制与抑制AQP-1和(或)AQP-5表达下调有关;而乳酸钠林格氏液对其无效.     

携带前强啡肽基因重组质粒的构建及鉴定

强啡肽(dynorphin)是作用于κ-阿片受体的神经肽,广泛分布于外周和中枢神经系统,涉及到许多生理和病理变化如吗啡耐受和依赖等[1].我们利用前强啡肽基因(prodynorphin gene)构建pUC57-prodynorphin重组质粒为下一步探讨其在吗啡耐受和依赖中的作用奠定了基础.     

80例急性前间壁心肌梗死患者右胸导联心电图分析

1993年～ 2 0 0 0年上半年 ,我们对心内科住院的急性心肌梗死 (ＡＭＩ)、陈旧性ＭＩ及诊断为冠心病的患者常规作 18导联心电图 ,即除常规 12导联外 ,加作Ｖ3Ｒ～Ｖ5Ｒ 和Ｖ7～Ｖ9导联心电图。现就 80例急性前间壁ＭＩ患者的右胸导联 (Ｖ3Ｒ～Ｖ5Ｒ)心电图作初步分析。 80例ＡＭＩ患者均符合下列条件 :①病史、心电图和心肌酶学检查确诊为ＡＭＩ。②发病后 6～14ｈ入院并有完整 18导联心电图资料和心肌酶学检查。③心电图定位为急性前间壁ＭＩ。④除外急性下壁、后壁、正后壁、高侧壁和侧壁等ＭＩ,并除外右心室肥大、肺心病、心包炎、心肌病…     

完全性左束支传导阻滞合并左室肥厚的心电图诊断

完全性左束支传导阻滞(CLBBB)时,诊断左室肥厚(LVH),比较困难。近年来LVH的超声诊断标准已被医学界公认。我们用彩色超声心动图(彩超)测定60例CLBBB的心脏大小,探讨CLBBB时伴LVH的心电图指标。